Skip to main content
Fig. 7 | Molecular Cancer

Fig. 7

From: MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway

Fig. 7

The prognostic value of miR-1296 and SRPK1 for HCC patients. a and b Overall survival (OS) and disease-free survival (DFS) were compared between miR-1296 high expressing HCC patients and low expressing cases. c and d OS and DFS were compared between SRPK1 high expressing HCC patients and low expressing cases. e and f OS and DFS were compared between four subgroups of HCC patients (subgroup I: high miR-1296/low SRPK1; subgroup II: low miR-1296 /low SRPK1; subgroup III: high miR-1296/high SRPK1; subgroup IV: low miR-1296/high SRPK1). For each cohort, subgroups were divided according to the cutoff values, which were determined as the median level of miR-1296 and SRPK1 in HCC tissues. **P < 0.01

Back to article page